NPPA fixed retail price of 51 formulations: September 2023

Last Updated on December 31, 2023 by The Health Master

Download NPPA notification No. S.O. 4076(E) dt 15-09-2023, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 51 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 4076(E) dt 15-09-2023.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Rosuvastatin & Clopidogrel Capsules	Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd / M/s Torrent Pharmaceuticals Limited	18.95
2	Diclofenac Diethylamine, Methyl Salicylate and Menthol Gel	Composition: Diclofenac Diethylamine IP 2.32 % w/w eq. to Diclofenac Sodium IP 2.0 % w/w Methyl Salicylate IP 10 % w/w Menthol IP 5 % w/w	1 Gram	M/s Daiwik Pharmasphere Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	4.08
3	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Abbott Healthcare Pvt. Ltd.	8.97
4	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 850mg	1 Tablet	M/s Sai Primus Life Biotech Private Limited / M/s Primus Remedies Pvt. Ltd.	12.18
5	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	9.60
6	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	8.97
7	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd.	8.97
8	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd.	9.60
9	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Abbott Healthcare Pvt. Ltd.	9.60
10	Pantoprazole Sodium (EC) & Levosulpiride (SR) Capsules	Each Hard gelatine capsule contains: Pantoprazole Sodium Sesquihydrate IP eq. to Pantoprazole 40mg (As Enteric Coated Pellets) Levosulpiride 75mg (As Sustained Release Pellets)	1 Capsule	M/s Lucent Biotech Limited / M/s Torrent Pharmaceuticals Ltd.	15.96
11	Budesonide and Formoterol Fumarate	Each 2 ml respule contains: Budesonide IP 1mg Formoterol Fumarate Dihydrate eq. to Formoterol Fumarate 20 mcg	Per 2 ml	M/s Axa Parenterals Ltd./ M/s J.B. Chemicals & Pharmaceuticals Ltd.	56.20
12	Itraconazole Capsules (Supra- Bioavailable Formulation)	Each Hard gelatine capsule contains: (Supra-Bioavailable formulation) Itraconazole IP 130mg	1 Capsule	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Dr. Reddy’s Laboratories Limited	19.30
13	Linagliptin + Metformin Hydrochloride Extended Release Tablet	Each film coated bilayer tablet contains: Linagliptin 2.5mg Metformin Hydrochloride (As extended release)IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	9.60
14	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	8.97
15	Linagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	9.60

16	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated bilayered tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 1000mg (as Extended release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd.	9.60
17	Itraconazole Capsules (Supra- Bioavailable Formulation)	Each Hard gelatine capsule contains: (Supra-Bioavailable formulation) Itraconazole IP 65mg	1 Capsule	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Dr. Reddy’s Laboratories Limited	10.81
18	Diclofenac Potassium & Metaxalone Tablets	Each uncoated tablet contains: Diclofenac Potassium IP 50mg Metaxalone USP 400mg	1 Tablet	M/s Windlas Biotech Limited / M/s Intas Pharmaceuticals Ltd.	15.08
19	Cefuroxime Axetil & Potassium Clavulanate Tablets	Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime 500mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 125mg	1 Tablet	M/s Hetero Labs Limited / M/s Sun Pharmaceuticals Industries Limited	55.23
20	Levosalbutamol and Ipratropium Bromide respule solution	Each 2.5ml contains: Levosalbutamol Sulphate IP eq. to Levosalbutamol 1.25mg Ipratropium Bromide IP eq. to Ipratropium (anhydrous) 500mcg	1 ML	M/s AXA Parenterals Ltd. / M/s Mankind Pharma Ltd.	5.49
21	Moxifloxacin Eye Drops	Composition: Moxifloxacin hydrochloride IP eq. to Moxofloxacin 0.5%w/v Preservative : Benzalkonium Chloride Solution IP 0.02% w/v	1 ML	M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Limited	17.00
22	Pantoprazole Dual Release Gastro Resistant Tablets	Each Dual Release Gastro Resistant Tablet Contains: Pantoprazole Sodium IP eq. to Pantoprazole 80mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Mankind Pharma Ltd.	15.30
23	Telmisartan, Chlorthalidone & Cilnidipine tablets	Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg Cilnidipine IP 10mg	1 Tablet	M/s Macleods Pharmaceuticals Ltd.	13.05
24	Povidone Iodine Gargle	Composition: Povidone Iodine IP 0.5% w/v (available Iodine 0.05% w/v)	1 ml	M/s Pontika Aerotech Limited / M/s Emcure Pharmaceuticals Limited	0.70
25	Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained Release) Tablets	Each Film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Limited / M/s Micro Labs Limited	16.07
26	Teneligliptin, Pioglitazone and Metformin Hydrochloride (as Sustained Release) Tablets	Each Film coated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin 20mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Limited / M/s Micro Labs Limited	17.85
27	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.	16.06

28	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited	16.06
29	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	16.06
30	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.	16.09
31	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s La Renon Healthcare Private Limited	16.09
32	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.	17.13
33	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited	17.13
34	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	17.13
35	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.	17.16

36	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s La Renon Healthcare Private Limited	17.16
37	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each film coated bilayer tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride IP (as Sustained Release) 500mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	18.00
38	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayer tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride (as Sustained Release) IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Alkem Laboratories Limited	16.29
39	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each film coated bilayer tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride IP (as Sustained Release) 1000mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd.	19.00
40	Dapagliflozin, Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (As Extende Release form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Alkem Laboratories Limited	14.59
41	Dapagliflozin, Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg (As Extende Release form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Alkem Laboratories Limited	13.62
42	Linagliptin + Metformin Hydrochloride Extended Release Tablet	Each film coated bilayer tablet contains: Linagliptin 5mg Metformin Hydrochloride (As extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	14.37
43	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride IP 1000mg (as Extended release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd.	14.37
44	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals Ltd. / M/s Micro Labs Ltd.	14.37
45	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	14.00

46	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Lupin Limited	14.37
47	Metoprolol Succinate Extended Release, Amlodipine 5mg & Telmisartan Tablet	Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (As Extended release) Amlodipine Besilate IP IP eq. to Amlodipine 5mg Telmisartan IP 40mg	1 Tablet	M/s Ajanta Pharma Limited	14.23
48	Ambroxol Hydrochloride, Salbutamol Sulphate, Guaiphenesin & Methol Liquid	Each 5ml contains: Ambroxol Hydrochloride IP 15mg Salbutamol Sulphate IP eq. to Salbutamol 1mg Guaiphenesin IP 50mg Methol IP 1mg	1 ml	M/s Naxpar Pharma Pvt. Ltd. / M/s Geno Pharmaceuticals Pvt. Ltd.	0.52
49	Glimepiride & Lobeglitazone Sulfate tablet	Each uncoated Bilayer tablet contains: Lobeglitazone Sulfate 0.5mg Glimepiride IP 1mg	1 Tablet	M/s Glenmark Pharmaceuticals Limited	11.39
50	Combikit of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP	Each Strip contains: Clarithromycin Tablets IP 2 Tablets Each film coated tablet contains: Clarithromycin IP 500mg Esomeprazole Tablets IP 2 Tablets Each Enteric coated tablet contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mgAmoxicillin Tablets USP 2 Tablets Each Film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 1000mg	Each Strip	M/s Malik Lifesciences Pvt. Ltd. / M/s Cipla Limited	151.98
51	Brinzolamide, Brimonidine Tartrate & Timolol Ophthalmic suspension	Each ml contains: Brinzolamide IP 10mg Brimonidine Tartrate IP 2 mg Timolol Maleate eq. to Timolol IP 5 mg Water for injection	1 ml	M/s Micro labs Limited	105.25

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Key Notes on Revised Schedule M: Point No. 14 – Materials
  December 25, 2024
• USFDA issues VAI status to Biocon for Bengaluru API facility
  December 25, 2024
• Bulk drug import from China continues to rise in 5 years
  December 25, 2024
• High Court stays action against Pharma Units manufacturing Nutraceuticals
  December 25, 2024
• NPPA fixed retail price of 7 formulations: December 2024
  December 24, 2024
• Revised Schedule M: Industry seeks balance between Quality and Viability
  December 24, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: